PRICE T ROWE ASSOCIATES INC /MD/

Position in TNGX — Tango Therapeutics, Inc.

CIK 80255 BALTIMORE, MD

Position in TNGX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$198,464,331

+$179,858,084 QoQ

Shares Held

6,348,827

+613.8% QoQ

Ownership

3.77%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#10

of 247 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. TNGX ranks #25 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	SRRK	Scholar Rock Holding Corp	6,794,837	$373,716,035

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$198,464,331	6,348,827	+613.8%	Shares	Sole	2026-08-14
2026-03-31	$18,606,247	889,400	+1422.1%	Shares	Defined	2026-05-15
2025-12-31	$517,724	58,434	+43.7%	Shares	Sole	2026-02-17
2025-09-30	$341,301	40,669	+5.9%	Shares	Sole	2025-11-14
2025-06-30	$196,613	38,401	+72.6%	Shares	Defined	2025-08-14
2025-03-31	$30,485	22,252	+6.0%	Shares	Defined	2025-05-14
2024-12-31	$64,883	20,998	+29.7%	Shares	Defined	2025-02-14
2024-09-30	$124,624	16,185	+6.2%	Shares	Defined	2024-11-14
2024-06-30	$130,707	15,234	+19.3%	Shares	Defined	2024-08-14
2024-03-31	$101,401	12,771	+12.6%	Shares	Defined	2024-05-15
2023-12-31	$112,315	11,345	+11.1%	Shares	Defined	2024-02-16
2023-09-30	$115,032	10,216	—	Shares	Defined	2023-11-14
No filing history on record for this holder in this stock.